Viewing Study NCT02376803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-05-09 @ 2:50 PM
Study NCT ID: NCT02376803
Status: COMPLETED
Last Update Posted: 2018-05-04
First Post: 2015-02-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
Sponsor: University of Alberta
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation View
None Thrombus Due to Heart Valve Prosthesis View
None Deep Venous Thrombosis View
None Thromboembolism View
None DVT View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Randomized controlled trial View
None Warfarin View
None Time in therapeutic range View
None Bleeding View
None Thromboembolic View
None Hemorrhage View
None Anticoagulant View
None TTR View
None Chronobiology View
None Chronotherapeutic View
None Coumadin View
None INR View
None International normalized ratio View
None RCT View